BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 6, 2007
View Archived Issues
DA-9102 improves atopic dermatitis in proof-of-concept trial
Read More
Eden Biodesign and Cancer Research UK sign development agreements for cancer drugs
Read More
Recent patents claim novel therapeutic agents for schizophrenia, depression and anxiety
Read More
Phoqus begins phase II trial of Chronocort for CAH
Read More
Novel ATP-sensitive potassium channel activators emerge from Janssen R&D
Read More
Recent Jerini patent imparts new therapeutic agents for ocular disorders
Read More
AMANET initiates clinical trial of malaria vaccine GMZ2 in Africa
Read More
InterMune's phase Ib amended CTA for ITMN-191 approved in Europe
Read More
Encysive completes patient enrollment of phase II trial of Thelin for DHF
Read More
Isis begins phase I trial of ISIS-325568 for type 2 diabetes
Read More
Septic shock treatment study questions guideline recommendations
Read More
Upregulation of ACE as a potential therapeutic strategy to reduce Abeta deposition in the AD brain
Read More
Promising preclinical results of intranasally delivered influenza A vaccine
Read More
Novel PET cardiac tracer profiled at BMS
Read More
MediGene completes patient recruitment for clinical trial of oncolytic virus
Read More
Ovation initiates U.S. phase III clobazam study in epilepsy
Read More
FDA fast tracks ATryn in antithrombin deficiency and allows rolling BLA submission
Read More
FDA grants fast track designation to AGI Dermatics' Dimericine for XP
Read More
Provectus to initiate phase II study of Provecta for metastatic melanoma
Read More
Icagen begins phase I study of ICA-105665 for epilepsy
Read More
USAN approves nonproprietary name adipiplon for Neurogen's NG2-73 for insomnia
Read More
Advanced Viral Research expects to begin phase II trial of AVR-118
Read More
Positive results for Clinical Data's pivotal phase III study of vilazodone for depression
Read More
Depomed reports results of phase IIa proof-of-concept study of omeprazole for GERD
Read More